Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Extracalm
- Development stage
- Unknown
- Lead developer
- Flen Health
- Administration
- Topical
01
Overview
Extracalm is a topical gel spray developed and marketed by Flen Health for the symptomatic relief of itchy, painful, red, or irritated skin. It is indicated for conditions such as senile pruritus, allergic reactions, and skin irritation following dermatological procedures like laser treatments or chemical peels. The product functions through a physical cooling mechanism that provides immediate relief for over 140 minutes and deposits a protective silicone film on the skin to restore moisture balance. Notably, Extracalm is cortisone-free and is intended for use on intact skin; it is explicitly not for use on open wounds.
- Brand names
- Extracalm
Beyond the preview
Go deeper on Extracalm.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Extracalm.